Jefferies Upgrades BioNTech to Buy, Raises Price Target to $150
Portfolio Pulse from Benzinga Newsdesk
Jefferies analyst Akash Tewari has upgraded BioNTech (NASDAQ:BNTX) from Hold to Buy and increased the price target from $96 to $150.
September 17, 2024 | 12:50 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Jefferies has upgraded BioNTech from Hold to Buy, raising the price target from $96 to $150, indicating a positive outlook on the stock.
The upgrade from Hold to Buy by Jefferies, along with a significant increase in the price target, suggests a strong positive sentiment towards BioNTech's future performance. This is likely to attract investor interest and potentially drive the stock price up in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100